Maria Grazia Roncarolo
Directeur/Membre du Conseil chez COSMO PHARMACEUTICALS N.V.
Fortune : 166 950 $ au 30/04/2024
Postes actifs de Maria Grazia Roncarolo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| COSMO PHARMACEUTICALS N.V. | Directeur/Membre du Conseil | 01/04/2012 | - |
| Independent Dir/Board Member | 01/04/2012 | - | |
| ATARA BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/05/2020 | - |
| Independent Dir/Board Member | 11/05/2020 | - | |
Ospedale San Raffaele Srl
 Ospedale San Raffaele Srl Hospital/Nursing ManagementHealth Services Ospedale San Raffaele Srl is engaged in hospital business. The company is headquartered in Milan, Italy. | Corporate Officer/Principal | 01/07/2003 | - |
| Academia Europaea Ltd | Corporate Officer/Principal | 01/01/2005 | - |
| Institute For Stem Cell Biology & Regenerative Medicine | Corporate Officer/Principal | 01/06/2014 | - |
| Stanford University | Corporate Officer/Principal | 01/03/2014 | - |
| Federation of Clinical Immunology Societies | President | 01/01/2018 | - |
Historique de carrière de Maria Grazia Roncarolo
Anciens postes connus de Maria Grazia Roncarolo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| San Raffaele School of Medicine | Corporate Officer/Principal | 01/03/2007 | 01/06/2014 |
Fondazione San Raffaele del Monte Tabor-Milano
 Fondazione San Raffaele del Monte Tabor-Milano Hospital/Nursing ManagementHealth Services Fondazione San Raffaele del Monte Tabor-Milano provides medical care and clinical support to patients. They carry out biomedical research and clinical activities. The company is based in Milan, Italy. | Directeur Technique/Scientifique/R&D | 01/01/2008 | 01/01/2013 |
| ░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Maria Grazia Roncarolo
| University of Turin | Doctorate Degree |
Statistiques
Internationale
| Italie | 7 |
| Etats-Unis | 6 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
| Health Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COSMO PHARMACEUTICALS N.V. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Cosmo Pharmaceuticals SA
 Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cosmo Pharmaceuticals SA operates as a pharmaceutical company that engages in the manufacturing of pharmaceutical drugs. It focuses on the development of gastro-intestinal pharmaceutical products for the treatment of inflammatory bowel diseases, colon infections and colon diagnosis, and treated skin disorders. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Lainate, Italy. | Health Technology |
Fondazione San Raffaele del Monte Tabor-Milano
Fondazione San Raffaele del Monte Tabor-Milano Hospital/Nursing ManagementHealth Services Fondazione San Raffaele del Monte Tabor-Milano provides medical care and clinical support to patients. They carry out biomedical research and clinical activities. The company is based in Milan, Italy. | Health Services |
Ospedale San Raffaele Srl
Ospedale San Raffaele Srl Hospital/Nursing ManagementHealth Services Ospedale San Raffaele Srl is engaged in hospital business. The company is headquartered in Milan, Italy. | Health Services |
| Academia Europaea Ltd | |
| Institute For Stem Cell Biology & Regenerative Medicine | |
| San Raffaele-Telethon Institute for Gene Therapy | |
| Federation of Clinical Immunology Societies | |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Maria Grazia Roncarolo
- Expérience
